SEC 13F Intelligence

Corbin Capital Partners, L.P. / ABUS

Corbin Capital Partners, L.P.’s Arbutus Biopharma Corp Position

Does Corbin Capital Partners, L.P. own Arbutus Biopharma Corp (ABUS)? Yes — 682.5K shares worth $2M (+3.64% of its 13F portfolio) as of Q4 2024, down from 853.3K shares the prior filed quarter.

Position Value
$2M
Q4 2024
Shares
682.5K
% of Portfolio
+3.64%
Quarters Held
4
currently held

Position History ABUS

Reported value by quarter
Q1 ’24: $2MQ1 ’24Q2 ’24: $2MQ2 ’24Q3 ’24: $3MQ3 ’24Q4 ’24: $2MQ4 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2024682.5K$2M+3.64%
Q3 2024853.3K$3M+4.15%
Q2 2024853.3K$2M+4.25%
Q1 2024853.3K$2M+3.72%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Corbin Capital Partners, L.P.’s full portfolio or all institutional holders of ABUS.